Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study

MLA

Liudmila G. Zhukova, et al. “Safety and Efficacy of Ribociclib in Combination with Letrozole in an Extended Population of Patients with HR+/HER2- Advanced Breast Cancer: Analysis of Data from a Subgroup of Patients from Russia in the Phase Lllb CompLEEment-1 Study.” Современная Онкология, vol. 26, no. 1, Mar. 2024, pp. 56–64. EBSCOhost, https://doi.org/10.26442/18151434.2024.1.202595.

APA

Liudmila G. Zhukova, Larisa V. Bolotina, Victoria V. Dvornichenko, Natalia V. Fadeeva, Inna P. Ganshina, Katerina S. Grechukhina, Alfiya I. Hasanova, Nikolay V. Kislov, Igor Yu. Kudryavtsev, Alexey G. Manikhas, Natalia E. Musaeva, Alexandra A. Nizhegorodtseva, Olga E. Sadikova, Dina D. Sakaeva, Anton V. Snegovoy, Daniil L. Stroyakovskiy, Sergei A. Tjulandin, Ekaterina A. Trishkina, Liubov Iu. Vladimirova, … Yulia V. Kostalanova. (2024). Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study. Современная Онкология, 26(1), 56–64. https://doi.org/10.26442/18151434.2024.1.202595

Chicago

Liudmila G. Zhukova, Larisa V. Bolotina, Victoria V. Dvornichenko, Natalia V. Fadeeva, Inna P. Ganshina, Katerina S. Grechukhina, Alfiya I. Hasanova, et al. 2024. “Safety and Efficacy of Ribociclib in Combination with Letrozole in an Extended Population of Patients with HR+/HER2- Advanced Breast Cancer: Analysis of Data from a Subgroup of Patients from Russia in the Phase Lllb CompLEEment-1 Study.” Современная Онкология 26 (1): 56–64. doi:10.26442/18151434.2024.1.202595.